Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT

Seres Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.79M 127.97M 163.03M 180M
Short-Term Investments
n/a n/a 18.31M 110.7M
Long-Term Investments
n/a n/a 9.59M 495K
Other Long-Term Assets
8.7M 50.94M 10.46M 14.59M
Receivables
4.75M 8.67M n/a n/a
Inventory
n/a 29.65M n/a n/a
Other Current Assets
3.13M 9.12M 13.42M 12.92M
Total Current Assets
38.67M 175.41M 194.76M 303.63M
Property-Plant & Equipment
92.44M 132.25M 133.97M 36.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
101.14M 183.19M 154.02M 51.23M
Total Assets
139.81M 358.6M 348.78M 354.86M
Account Payables
4.08M 3.64M 17.44M 13.73M
Deferred Revenue
n/a 7.73M 4.26M 16.82M
Short-Term Debt
8.67M n/a 456K 6.61M
Other Current Liabilities
28.47M 64.15M 90.26M 29.27M
Total Current Liabilities
41.22M 98.66M 85.6M 82.26M
Long-Term Debt
n/a 101.54M 50.59M 24.64M
Other Long-Term Liabilities
1.84M 2.17M 1.44M 11.49M
Total Long-Term Liabilities
84.8M 304.8M 252.41M 141.09M
Total Liabilities
126.03M 403.46M 338M 223.35M
Total Debt
91.64M 213.94M 162.59M 49.21M
Common Stock
173K 135K 125K 92K
Retained Earnings
-978.1M -978.24M -864.51M -614.35M
Comprehensive Income
n/a n/a -12K -60K
Shareholders Equity
13.78M -44.86M 10.78M 131.51M
Total Investments
n/a 9.59M 18.31M 111.2M